Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dimethylhydrazine | increases expression | EXP | | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of ACAP1 mRNA | CTD | PMID:22206623 | 1-naphthyl isothiocyanate | decreases expression | ISO | Acap1 (Rattus norvegicus) | 6480464 | 1-Naphthylisothiocyanate results in decreased expression of ACAP1 mRNA | CTD | PMID:30723492 | 17beta-estradiol | multiple interactions | ISO | Acap1 (Rattus norvegicus) | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ACAP1 mRNA | CTD | PMID:32741896 | 17beta-estradiol 3-benzoate | multiple interactions | ISO | Acap1 (Rattus norvegicus) | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ACAP1 mRNA | CTD | PMID:32741896 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Acap1 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of ACAP1 mRNA | CTD | PMID:34747641 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Acap1 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ACAP1 mRNA | CTD | PMID:33387578 | 3,3',5,5'-tetrabromobisphenol A | increases expression | EXP | | 6480464 | tetrabromobisphenol A results in increased expression of ACAP1 mRNA | CTD | PMID:25172293 | 4,4'-sulfonyldiphenol | increases methylation | EXP | | 6480464 | bisphenol S results in increased methylation of ACAP1 exon | CTD | PMID:33297965 | 6-propyl-2-thiouracil | decreases expression | ISO | Acap1 (Rattus norvegicus) | 6480464 | Propylthiouracil results in decreased expression of ACAP1 mRNA | CTD | PMID:24780913 | acetamide | increases expression | ISO | Acap1 (Rattus norvegicus) | 6480464 | acetamide results in increased expression of ACAP1 mRNA | CTD | PMID:31881176 | antirheumatic drug | affects expression | ISO | ACAP1 (Homo sapiens) | 6480464 | Antirheumatic Agents affects the expression of ACAP1 mRNA | CTD | PMID:24449571 | arsane | multiple interactions | ISO | ACAP1 (Homo sapiens) | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of ACAP1 mRNA | CTD | PMID:32525701 | arsenic atom | multiple interactions | ISO | ACAP1 (Homo sapiens) | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of ACAP1 mRNA | CTD | PMID:32525701 | benzo[a]pyrene | affects methylation | ISO | ACAP1 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of ACAP1 promoter | CTD | PMID:27901495 | bisphenol A | increases expression | ISO | Acap1 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of ACAP1 mRNA | CTD | PMID:25181051 and PMID:34947998 | bisphenol A | decreases expression | ISO | ACAP1 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of ACAP1 mRNA | CTD | PMID:36232920 | bisphenol A | increases methylation | ISO | ACAP1 (Homo sapiens) | 6480464 | bisphenol A results in increased methylation of ACAP1 gene | CTD | PMID:31601247 | buta-1,3-diene | decreases expression | EXP | | 6480464 | 1 and 3-butadiene results in decreased expression of ACAP1 mRNA | CTD | PMID:29038090 | chloroprene | decreases expression | EXP | | 6480464 | Chloroprene results in decreased expression of ACAP1 mRNA | CTD | PMID:23125180 | chlorpyrifos | increases expression | EXP | | 6480464 | Chlorpyrifos results in increased expression of ACAP1 mRNA | CTD | PMID:32715474 | cisplatin | decreases expression | ISO | ACAP1 (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of ACAP1 mRNA | CTD | PMID:27392435 | copper(II) sulfate | increases expression | ISO | ACAP1 (Homo sapiens) | 6480464 | Copper Sulfate results in increased expression of ACAP1 mRNA | CTD | PMID:19549813 | cytarabine | increases expression | ISO | ACAP1 (Homo sapiens) | 6480464 | Cytarabine results in increased expression of ACAP1 mRNA | CTD | PMID:19194470 | dimethylarsinic acid | multiple interactions | EXP | | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ACAP1 mRNA | CTD | PMID:34876320 | dorsomorphin | multiple interactions | ISO | ACAP1 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACAP1 mRNA | CTD | PMID:27188386 | entinostat | multiple interactions | ISO | ACAP1 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACAP1 mRNA | CTD | PMID:27188386 | gentamycin | increases expression | ISO | Acap1 (Rattus norvegicus) | 6480464 | Gentamicins results in increased expression of ACAP1 mRNA | CTD | PMID:22061828 and PMID:33387578 | lipopolysaccharide | multiple interactions | ISO | ACAP1 (Homo sapiens) | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ACAP1 mRNA | CTD | PMID:35811015 | lipopolysaccharide | decreases expression | ISO | ACAP1 (Homo sapiens) | 6480464 | Lipopolysaccharides results in decreased expression of ACAP1 mRNA | CTD | PMID:35811015 | manganese(II) chloride | increases expression | ISO | Acap1 (Rattus norvegicus) | 6480464 | manganese chloride results in increased expression of ACAP1 mRNA | CTD | PMID:28801915 | methylarsonic acid | multiple interactions | EXP | | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ACAP1 mRNA | CTD | PMID:34876320 | mono(2-ethylhexyl) phthalate | increases expression | EXP | | 6480464 | mono-(2-ethylhexyl)phthalate results in increased expression of ACAP1 mRNA | CTD | PMID:22401849 | nickel atom | increases expression | ISO | ACAP1 (Homo sapiens) | 6480464 | Nickel results in increased expression of ACAP1 mRNA | CTD | PMID:25583101 | ozone | decreases expression | ISO | Acap1 (Rattus norvegicus) | 6480464 | Ozone results in decreased expression of ACAP1 mRNA | CTD | PMID:28623178 | ozone | multiple interactions | EXP | | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of ACAP1 mRNA and [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of ACAP1 mRNA | CTD | PMID:34911549 | paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of ACAP1 mRNA | CTD | PMID:17562736 | potassium dichromate | decreases expression | EXP | | 6480464 | Potassium Dichromate results in decreased expression of ACAP1 mRNA | CTD | PMID:23608068 | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | ACAP1 (Homo sapiens) | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ACAP1 mRNA | CTD | PMID:35811015 | SB 431542 | multiple interactions | ISO | ACAP1 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACAP1 mRNA | CTD | PMID:27188386 | silicon dioxide | increases expression | EXP | | 6480464 | Silicon Dioxide results in increased expression of ACAP1 mRNA | CTD | PMID:29341224 | sodium arsenate | multiple interactions | ISO | ACAP1 (Homo sapiens) | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of ACAP1 mRNA | CTD | PMID:32525701 | sodium arsenate | multiple interactions | EXP | | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ACAP1 mRNA | CTD | PMID:34876320 | sodium arsenite | multiple interactions | EXP | | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ACAP1 mRNA | CTD | PMID:34876320 | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of ACAP1 mRNA | CTD | PMID:37682722 | succimer | multiple interactions | EXP | | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in increased expression of ACAP1 mRNA | CTD | PMID:21641980 | sunitinib | increases expression | ISO | ACAP1 (Homo sapiens) | 6480464 | Sunitinib results in increased expression of ACAP1 mRNA | CTD | PMID:31533062 | testosterone | multiple interactions | ISO | Acap1 (Rattus norvegicus) | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ACAP1 mRNA | CTD | PMID:32741896 | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of ACAP1 mRNA | CTD | PMID:17484886 | thioacetamide | increases expression | ISO | Acap1 (Rattus norvegicus) | 6480464 | Thioacetamide results in increased expression of ACAP1 mRNA | CTD | PMID:34492290 | triptonide | increases expression | EXP | | 6480464 | triptonide results in increased expression of ACAP1 mRNA | CTD | PMID:33045310 | trovafloxacin | decreases expression | EXP | | 6480464 | trovafloxacin results in decreased expression of ACAP1 mRNA | CTD | PMID:35537566 | |